Singapore Clinical Research Institute
3 clinical trials · Sponsor
◉ Watch Singapore Clinical Research Institute
| Record | Firm | Date |
|---|---|---|
| Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers (NCT02140996) | Singapore Clinical Research Institute | 2014-09-01 |
| The Effect of 90-day Oral Testosterone Therapy in Chinese Males With Type 2 Diabetes (T2DM) (NCT01510847) | Singapore Clinical Research Institute | 2011-10-01 |
| Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) (NCT00712790) | Singapore Clinical Research Institute | 2008-06-01 |
Track Singapore Clinical Research Institute automatically
Every clearance here is in the API, with alerts when new ones post.